"Advanced lipid panel" is a label labs use for bundles of tests that go beyond the standard cholesterol panel. What's inside varies a lot from one lab to the next.
Some of those extra markers are among the most useful numbers in heart disease prevention. Others are interesting but rarely change what you or your clinician should do. This guide sorts them out, so you can decide whether a big panel is worth it or whether two targeted tests will do.
Key Takeaway
The two markers in advanced panels with the strongest evidence are ApoB and Lp(a). The 2026 US cholesterol guideline recommends Lp(a) once for every adult and supports ApoB in several situations, while it recommends against routine LDL particle size and subclass testing. For most people, ApoB plus Lp(a) plus a standard lipid panel covers what matters.
What a standard lipid panel measures
A standard lipid panel measures total cholesterol, HDL cholesterol, and triglycerides. LDL cholesterol (LDL-C) is usually calculated from those, and non-HDL cholesterol (total minus HDL) is often reported too. The test costs little, insurance widely covers it, and it still anchors cholesterol treatment.
It leaves out how many cholesterol-carrying particles you have, and whether you inherited high Lp(a). Advanced panels try to fill that gap.
What's in common advanced panels
Most advanced panels add some mix of ApoB, Lp(a), LDL particle number and size, and HDL particle measures to a standard lipid panel. Exactly which ones depends on the lab and the panel. Here's what the most commonly ordered panels include, from the labs' own test listings.
Quest Diagnostics Cardio IQ Advanced Lipid Panel. Cardio IQ is Quest's brand for its cardiovascular tests. The Advanced Lipid Panel includes:
- Total cholesterol, HDL cholesterol, and triglycerides
- ApoB
- Lp(a)
- Lipoprotein fractionation by ion mobility, which reports LDL particle number, small and medium LDL, large HDL, LDL pattern, and LDL peak size
The "with inflammation" version adds hs-CRP and Lp-PLA2.
Labcorp NMR LipoProfile. This test uses nuclear magnetic resonance (NMR) to count particles. It reports:
- LDL particle number (LDL-P), small LDL particles, and LDL particle size
- Total HDL particle number
- An insulin resistance score called LP-IR
- A standard lipid panel
The NMR LipoProfile on its own leaves out ApoB and Lp(a), so you add those separately.
Consumer versions. You can also buy advanced panels directly, without a clinician visit. These are the prices listed on each company's site as of October 2026:
Consumer advanced panels, as of October 2026
For comparison, the single tests are much cheaper: Labcorp OnDemand lists Lp(a) at $49 and ApoB at $69 (regular price), and Quest Health lists Lp(a) at $45 plus a $6 fee. Our guide on how to get an ApoB or Lp(a) test has the details.
The markers with the strongest evidence
ApoB and Lp(a) have the strongest evidence of any markers in an advanced panel, and both can be ordered on their own.
ApoB
Every particle that can lodge in an artery wall and start plaque (LDL, VLDL, and Lp(a) particles) carries exactly one ApoB protein. So ApoB is effectively a particle count. It matters most when standard numbers can mislead, such as with high triglycerides, diabetes, or a very low LDL cholesterol on treatment.
The 2026 ACC/AHA guideline says measuring ApoB is reasonable for people on cholesterol treatment, particularly those with heart disease, diabetes, kidney and metabolic conditions, or high triglycerides, to decide whether treatment should go further. It also says ApoB may be reasonable to sharpen risk assessment in people not yet on treatment. More in our ApoB guide.
Lp(a)
Lp(a) is an inherited particle that raises the risk of heart attack, stroke, and aortic valve narrowing. About 1 in 5 people have a high level, and the only way to know is to test. The 2026 guideline recommends measuring it at least once in every adult. More in our Lp(a) guide.
Source
Blumenthal RS, Morris PB, Gaudino M, et al. “2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Journal of the American College of Cardiology (2026).
View paperLDL particle number: useful, but ApoB usually does the job
LDL particle number (LDL-P) is the headline result of the NMR LipoProfile and the Cardio IQ ion mobility test. Like ApoB, it estimates how many plaque-forming particles you have, and in most people the two numbers line up closely.
The practical differences:
- ApoB is one standardized test. Labs calibrate ApoB to an international reference standard, so a result from one lab means roughly the same thing at another. Most labs also run it, and it costs little.
- LDL-P depends on the method. NMR and ion mobility are different technologies, run by different companies, so their particle counts aren't directly interchangeable.
- ApoB counts a little more. ApoB includes VLDL and Lp(a) particles along with LDL, which is why guidelines use it as the measure of total plaque-forming particles.
If you already have an LDL-P result, keep it: a high particle count is a real signal. But if you're choosing what to order, ApoB gives you the particle number for a fraction of the price.
Markers that add little for most people
Particle size, HDL subfractions, and newer inflammation markers rarely change treatment for most people. hs-CRP is the partial exception, in a narrow situation.
LDL particle size, pattern, and small dense LDL
Particle size draws the most attention in advanced panels and has the least evidence behind it. Small, dense LDL particles tend to come with high triglycerides and insulin resistance. In large studies, once researchers account for the total number of particles (ApoB or LDL-P) and triglycerides, the extra risk tied to particle size mostly fades away.
The 2026 ACC/AHA guideline is direct about this. It recommends against routine advanced lipoprotein testing to assess subclasses and particle size, whether by NMR, ion mobility, or other methods, rating it a "no benefit" recommendation. In plain terms, the count matters and the size rarely changes the plan.
HDL particle measures
Large HDL and HDL particle number are interesting research measures, but treatments that raise HDL haven't been shown to prevent heart attacks, and these numbers don't usually change cholesterol treatment. Our HDL guide covers why "good cholesterol" is more complicated than its nickname.
Lp-PLA2, GlycA, and insulin resistance scores
Lp-PLA2 and GlycA are inflammation-related markers. Aetna's coverage policy lists both as experimental and investigational. LP-IR and the Diabetes Risk Index estimate insulin resistance; if that's the question, standard tests like fasting glucose and A1c are the usual starting point.
hs-CRP: sometimes useful
High-sensitivity CRP measures low-level inflammation. It can help in a specific situation: someone at borderline risk, not on a statin, where the decision to start treatment is a close call. Aetna, for example, covers it for that scenario. For most people, it doesn't replace ApoB or Lp(a).
Cost and insurance coverage
Surprise bills tend to come from bundled panels. Insurers often cover some markers in a panel and not others:
- Usually covered when ordered for a reason: the standard lipid panel, a one-time Lp(a) test (more plans now cover this after the 2026 guideline), and ApoB in specific situations.
- Often not covered: particle size and subclass testing. Aetna's policy (Clinical Policy Bulletin 0381, checked October 2026) lists the NMR LipoProfile and LDL subspecies testing as experimental, along with Lp-PLA2 and GlycA.
- Medicare: Medicare's lab policies in many regions allow individual markers such as ApoB and Lp(a) when ordered for a documented reason, but not broad cardiovascular risk panels.
If you're paying cash, two single tests (ApoB and Lp(a)) usually cost well under the price of a full advanced panel.
When an advanced panel is worth it
An advanced panel earns its cost mainly as a convenient way to measure ApoB and Lp(a) if you haven't had them checked. It can make sense if:
- You've never had ApoB or Lp(a) measured, and a bundle that includes both is convenient or priced close to buying them separately
- You have high triglycerides, diabetes, or metabolic syndrome, where LDL cholesterol can understate your particle count
- Your LDL cholesterol looks fine but you have a strong family history of early heart disease
- You're on treatment and your clinician wants to see whether your particle count has caught up with your LDL
You can probably skip it if:
- You've already had Lp(a) tested (once is enough for most adults) and just need ApoB, which you can order alone
- The main appeal is particle size or "pattern B," which the 2026 guideline says shouldn't drive treatment decisions
- Your insurance would cover the standard panel, ApoB, and Lp(a) but not the rest of the bundle
Fasting and preparation
Advanced panels usually ask you to fast. Labcorp lists an 8 to 12 hour fast for the NMR LipoProfile, and Quest Health recommends 8 to 12 hours for its Advanced Heart Health panel. Water is fine. ApoB and Lp(a) on their own aren't much affected by meals, but follow your lab's instructions.
How Preval Health approaches advanced testing
Our protocols, written by a board-certified preventive cardiologist, focus on the markers that change treatment decisions: ApoB, Lp(a), and the lipid panel, along with other markers when the protocol calls for them. Licensed clinicians through our partner telehealth network order that testing as part of care, or work from results you already have, including advanced panels from Function Health, Superpower, Quest, or Labcorp. Then they treat to a target and recheck on a schedule that matches the medication.
See our advanced lipid testing page for how the labs work, or see how our cash practice works. If your ApoB comes back high, our guide on how to lower ApoB is a good next read.
Summary
ApoB and Lp(a) carry the strongest evidence and are worth knowing. Particle size, HDL subfractions, and newer inflammation markers rarely change what happens next for most people. Know your numbers, and spend your money on the ones that lead to a decision.